Mandatory disclosure of trade by primary insiders or close associates in IDEX Biometrics

26 Jan 2026 19:30 CET

Reference is made to IDEX Biometrics ASA's disclosure on 4 December 2025 of a
private placement of 7,333,333 shares at NOK 3.00 per share, split into two
tranches.

The Tranche 2 shares were approved by the Company's EGM on 20 January 2026. In
tranche 2 of the private placement includes 1,642,363 shares.

IDEX discloses the following information on behalf of primary insider.

Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten,
subscribed to 616,667 shares at NOK 3.00 per share. After the subscription by
Pinchcliffe, Mr. Storbråten and close relations hold 12,335,515 or 18,97%
shares of the total outstanding shares and votes in IDEX Biometrics after
completion of Tranche 2.

Contacts
Anders Storbråten, CEO and CFO, Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com

About Us
IDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.

IDEX Biometrics is advancing the future of access and payments with
identity-first biometrics. With over a decade of proprietary innovation, our
solutions are proven in the field, globally certified, and trusted by leading
financial institutions. We serve enterprises, the public sector, banks, and
issuers directly and through partners, delivering secure, seamless experiences
in digital and physical access and payments.

For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com/)

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-01-26 19:30
CET.

More information:
Access the news on Oslo Bors NewsWeb site

664226_Mandatory disclosure of trade by primary insiders or close associates in IDEX Biometrics.pdf